Testosterone Treatment in Women with Endometriosis
Testosterone treatment is not recommended for women with endometriosis as it is not supported by high-quality evidence and carries unclear long-term health effects. 1
Current Evidence on Testosterone in Endometriosis
While there is some historical and emerging evidence regarding testosterone and endometriosis, current clinical guidelines do not support testosterone as a primary treatment option:
- The ESHRE guideline clearly states that androgen treatment (including testosterone) is only supported by limited data, and long-term health effects remain unclear 1
- If androgen therapy is ever considered, treatment effect should be evaluated after 3-6 months and should possibly be limited to 24 months maximum 1
- ACOG recommendations for endometriosis management do not include testosterone among their evidence-based treatments 1
Recommended Treatment Options for Endometriosis
Current guidelines recommend the following evidence-based treatments for endometriosis:
First-line Medical Therapies (Level A/B Evidence)
- GnRH agonists for at least three months 1
- Danazol for at least six months 1
- Oral contraceptives 1
- Oral or depot medroxyprogesterone acetate 1
- NSAIDs for pain management 1
For Women Who Have Had Oophorectomy
- Combined estrogen/progestogen therapy is effective for vasomotor symptoms and may reduce disease reactivation risk 1
Why Testosterone Is Not Recommended
Limited Evidence Base: Current guidelines emphasize that androgen treatments have insufficient supporting data 1
Unknown Long-term Effects: The long-term health consequences of testosterone treatment in women with endometriosis are not well established 1
Better Alternatives Exist: Several well-studied alternatives with stronger evidence bases are available 1
Monitoring Challenges: If testosterone were used, it would require careful monitoring and time-limited treatment 1
Emerging Research
Recent research suggests some interesting connections between testosterone and endometriosis:
- Some studies indicate an inverse relationship between testosterone levels and endometriosis, with lower testosterone levels potentially associated with endometriosis and increased pain sensitivity 2
- In transmasculine individuals receiving testosterone therapy, there may be potential benefits for endometriosis symptoms 3
However, these findings are preliminary and have not yet translated into evidence-based clinical recommendations.
Clinical Approach to Endometriosis Management
For women with endometriosis requiring treatment:
First-line options:
For severe endometriosis:
For women post-oophorectomy:
- Combined estrogen/progestogen therapy is recommended 1
Important Caveats
- Historical use of testosterone for endometriosis (mentioned in older literature) 4, 5 has been superseded by treatments with stronger evidence bases
- Continuous combined hormone preparations or tibolone appear to be optimal choices for women requiring HRT after surgical treatment for endometriosis 6
- Unopposed estrogen carries a higher risk of endometriosis recurrence than combined preparations 6
In conclusion, while testosterone has historical use in endometriosis treatment and some emerging research suggests potential connections, current clinical guidelines do not support testosterone as a recommended treatment for women with endometriosis due to limited evidence and unclear long-term effects.